Principal Investigator: Dr Mattéa Finelli, University of Nottingham
464 results
Principal Investigator: Dr Manuela Natoli, The Francis Crick Institute
Principal Investigator: Dr Julia Needham, MRC London Institute of Medical Sciences
Principal Investigator: Professor Victoria Hutter, University of Hertfordshire
Principal Investigator: Dr Fiona Murphy, University of Strathclyde
Principal Investigator: Dr Ildem Akerman, University of Birmingham
Principal Investigator: Dr Pablo Céspedes, University of Oxford
Principal Investigator: Dr Lahiru Handunnetthi, University of Oxford
Principal Investigator: Dr Gowsihan Poologasundarampillai, University of Birmingham
The research team of Professors Bazbek Davletov and Andrew Peden, long-term collaborators at the University of Sheffield, have developed in vitro, cell-based assays for replacing animal testing in the manufacture of clostridial toxin-based medical products.
Principal Investigator: Dr Michael Colman, University of Leeds
Principal Investigator: Dr Anna Krasnodembskaya, Queen's University Belfast
With a decade of NC3Rs funding, scientists at the University of Birmingham have developed the first mature bone organotypic model, then systematically adapted and modified it to replace the use of rodents across a range of therapeutic areas involving the study of bone growth and regeneration.
Principal Investigator: Dr Inés Cebola, Imperial College London
Principal Investigator: Dr Pierre-Alexis Mouthuy, University of Oxford
Principal Investigator: Dr Alice Pollitt, University of Reading
Principal Investigator: Professor Amir Ghaemmaghami, University of Nottingham
Contractor: Professor Toni Cathomen, University of Freiburg
Principal Investigator: Professor Stephanie Dakin, University of Oxford
Professor Anthony Chalmers and Co-Investigator Dr Natividad Gomez-Roman have further developed a 3D human cell culture model replacing the use of mice to evaluate and screen treatments for Glioblastoma (GBM).
